# Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

> **NCT01035190** · PHASE3 · COMPLETED · sponsor: **University Children's Hospital Tuebingen** · enrollment: 863 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT01035190
- **Lead sponsor:** University Children's Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-10
- **Final completion:** 2016-07
- **Target enrollment:** 863 (ACTUAL)
- **Last updated:** 2016-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01035190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01035190, "Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01035190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*